Japanese researchers have introduced stem cells as part of the efforts to treat Parkinson's disease in the brain, a study from Kyoto University today. They clarified that iPS stem cells, which have the ability to convert to any type of cell in the body, were introduced to men in the 50's during the operation they performed in October. The man is stable and will supervise two years, reports the French Press Office AFP.
IPS stem cells are adult stem cells that have been returned to embryonic stem cells by genetic modification.
In the left part of the brain, 2.4 million stem cells were introduced into iPS, induced pluripotent stem cells. The intervention lasted for three hours. If the patient has no problems in the next six months, the same number of stem cells will be added to the right of the brain. Stem cells obtained from healthy donors have been developed into the precursors of dopamine-producing brain cells that die in patients with Parkinson's disease, citing AFP.
The University conducted the above-mentioned procedure when it was announced in July that this type of treatment should be tested in seven patients between the ages of 50 and 69 years. They decided to do this after successful experiments in monkeys, which after the introduction of these iPS cells in the brain significantly improved their motor skills. In two years, they have not developed tumors in the brain.
This is the first case in an attempt to treat Parkinson's disease by injecting stem cells into the brain. Parkinson's disease is a chronic neurodegenerative disease, the cause of which is unknown. Due to the decay of dopamine neurons in the brain, the disease develops continuously and can not be completely cured. Major motor symptoms are slow motion, muscle stiffness, daring and balance. Among the many non-motor symptoms are emotional disorders, psychosis, sleep disorders, gastrointestinal disorders and various sensory problems.
In the world, according to the Parkinson's disease fund, about 10 million people. About 7000 patients with Parkinson's disease live in Slovenia.